GLP1R and obesity due to melanocortin 4 receptor deficiency: GLP-1 receptor agonists have become increasingly important, first in managing type 2 diabetes mellitus (T2DM) for improved blood sugar control and later as a significant breakthrough in obesity management, demonstrating remarkable efficacy for weight loss [117].